中国临床药学杂志

参考文献

[1]LING W H,SOE P P,PANG A S,et al.Hepatitis B virus reactivation risk varies with different chemotherapy regimens commonly used in solid tumours[J].Br J Cancer,2013,108(10):1931.

[2]SARIN S K, KUMAR M,LAU G K,et al.Asian-Pacific clinical practice guidelines on the management of hepatitis B:a 2015update[J].Hepatol Int,2016,10(1):1.

[3]LIN G N,PENG J W,XIAO J J,et al.Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy:the efficacy of preemptive lamivudine and identification of risk factors[J].Med Oncol,2014,31(8):119.

[4]尤红,王福生,李太生,等.慢性乙型肝炎防治指南(2022年版)[J].实用肝脏病杂志,2023,26(3):457.

[5]PAPATHEODORIDIS G V, LEKAKIS V,VOULGARIS T,et al.Hepatitis B virus reactivation associated with new classes of immunosuppressants and immunomodulators:a systematic review,meta-analysis,and expert opinion[J].J Hepatol,2022,77(6):1670.

[6]PERRILLO R P, GISH R,FALCK-YTTER Y T.American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy[J].Gastroenterology,2015,148(1):221.

[7]HSU C H,HSU H C,CHEN H L.et al.Doxorubicin activates hepatitis B virus(HBV)replication in HBV-harboring hepatoblastoma cells.A possible novel mechanism of HBV reactivation in HBV carriers receiving systemic chemotherapy[J].Anticancer Res,2004,24(5A):3035.

[8]CHEN Y F,CHONG C L,WU Y C,et al.Doxorubicin activates hepatitis B virus replication by elevation of p21(Wafl/Cipl)and C/EBPa expression[J].PLoS One,2015,10(6):e0131743.

[9]WANG J,JIA J Q,CHEN R,et al.RFX1 participates in doxorubicin-induced hepatitis B virus reactivation[J].Cancer Med,2018,7(5):2021.

[10]XU L,TU Z,XU G,et al.Epirubicin directly promotes hepatitis B virus(HBV)replication in stable HBV-expressing cell lines:a novel mechanism of HBV reactivation following anticancer chemotherapy[J].Mol Med Rep,2014,9(4):1345.

[11]SHOJI T,KANAMORI M,INOUE J,et al.Hepatitis B virusreactivation during temozolomide administration for malignant glioma[J].Int J Clin Oncol,2021,26(2):305.

[12]VOICAN C S,MIR O,LOULERGUE P, et al.Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment[J].Ann Oncol,2016.27(12):2172.

[13]CROSBY J,SMITH F,GANTI S S,et al.Hepatitis B virus reactivation following treatment of HNSCC with cisplatin[J].J Investig Med High Impact Case Rep,2022,10:23247096221090842.

[14]RUAN J,SUN S,CHENG X,et al.Mitomycin,5-fluorouracil,leflunomide,and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro[J].Virol J,2020,17(1):89.

[15]KARACA M,TURAL D,AKAR E,et al.Hepatitis B reactivation rate is higher undergoing some cytotoxic chemotherapy in patients with solid tumors:a large retrospective study[J].Chemotherapy,2018,63(5):247.

[16]DAY F L,LINK E,THURSKY K,et al.Current hepatitis B screening practices and clinical experience of reactivation in patients undergoing chemotherapy for solid tumors:a nationwide survey of medical oncologists[J].J Oncol Pract,2011,7(3):141.

[17]LI J,HUANG B H,LI Y,et al.Hepatitis B virus reactivation in patients with multiple myeloma receiving bortezomib-containing regimens followed by autologous stem cell transplant[J].Leuk Lymphoma,2015,56(6):1710.

[18]GONZALEZ S A,PERRILLO R P.Hepatitis B virus reactivation in the setting of cancer chemotherapy and other immunosuppressive drug therapy[J].Clin Infect Dis,2016,62(Suppl 4):306.

[19]INAYAT F,SONG F,ALI N S,et al.Hepatitis B virus reactivation following imatinib therapy:a comparative review of 9 cases[J].J Oncol Pharm Pract,2019,25(6):1500.

[20]INNOCENTI I,REDA G,VISENTIN A,et al.Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis.A retrospective multicentric GIMEMA study[J].Haematologica,2022,107(6):1470.

[21]邱效东,常亚丽,周亚伟,等.伊布替尼致乙肝病毒再激活1例报告并文献复习[J].山东医药,2020,60(26):57.

[22]GIAMMARCO S,PEFFAULT DE LATOUR R,SICA S,et al.Transplant outcome for patients with acquired aplastic anemia over the age of 40:has the outcome improved?[J].Blood,2018,131(17):1989.

[23]LAI G M,YAN S L,CHANG C S,et al.Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor[J].World J Gastroenterol,2013,19(8):13 18.

[24]ANDO T,KOJIMA K,ISODA H,et al.Reactivation of resolved infection with the hepatitis B virus immune escape mutant G145R during dasatinib treatment for chronic myeloid leukemia[J].Int J Hematol,2015,102(3):379.

[25]王惠,凌青霞,庄一心.非小细胞肺癌患者表皮生长因子受体酪氨酸激酶抑制剂治疗中乙肝再激活发生率[J].中国肿瘤临床与康复,2022,29(2):134.

[26]YAO Z H,LIAO W Y,HO C C,et al.Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non-small-cell lung cancer patients[J].Eur J Cancer,2019,117:107.

[27]LEE P H,HUANG Y H,HSU Y W,et al.Reactivation of hepatitis B virus in lung cancer patients receiving tyrosine kinase inhibitor treatment[J].J Clin Med,2022,12(1):231.

[28]EVENS A M,JOVANOVIC B D, SU Y C,et al.Rituximabassociated hepatitis B virus(HBV)reactivation in lymphoproliferative diseases:meta-analysis and examination of FDA safety reports[J].Ann Oncol,2011,22(5):1170.

[29]KUSUMOTO S,ARCAINI L,HONG X N,et al.Risk of HBV reactivation in patients with B-cell ly mphomas receiving obinutuzumab or rituximab immunochemotherapy[J].Blood,2019,133(2):137.

[30]CAO X,WANG Y F,LI P Y,et al.HBV reactivation during the treatment of non-hodgkin lymphoma and management strategies[J].Front Oncol,2021,11:685706.

[31]KREJCIK J,CASNEUF T,NIJHOF I S,et al.Daratumumab depletes CD38+immune regulatory cells,promotes T-cell expansion,and skews T-cell repertoire in multiple myeloma[J].Blood,2016,128(3):384.

[32]IANNITTO E,MINARDI V,CALVARUSO G,et al.Hepatitis B virus reactivation and alemtuzumab therapy[J].Eur J Haematol,2005,74(3):254.

[33]TOTANI H,KUSUMOTO S,ISHIDA T,et al.Reactivation of hepatitis B virus(HBV)infection in adult T-cell leukemialymphoma patients with resolved HBV infection following systemic chemotherapy[J].Int J Hematol,2015,101(4):398.

[34]ARASANZ H,GATO-CA?AS M,ZUAZO M,et al.PD1 signal transduction pathways in T cells[J].Oncotarget,2017,8(31):51935.

[35]BURNS E A,MUHSEN I N,ANAND K,et al.Hepatitis B virus reactivation in cancer patients treated with immune checkpoint inhibitors[J].J Immunother,2021,44(3):132.

[36]ZHAO J,ZHANG Y H,QIN S Y,et al.Hepatitis B virusreactivation in cancer patients undergoing immune checkpoint inhibitors therapy:a systematic review[J].J Cancer,2022,13(14):3539.

[37]中国抗癌协会血液肿瘤专业委员会,中华医学会血液学分会.靶向B细胞和浆细胞的CAR-T细胞治疗中防治乙型肝炎病毒再激活的中国专家共识(2021年版)[J].中华血液学杂志,2021,42(6):441.

[38]CAO W Y,WEI J,WANG N,et al.Entecavir prophylaxis for hepatitis B virus reactivation in patients with CAR T-cell therapy[J].Blood,2020,136(4):516.

[39]MUSTAFAYEV K,TORRES H.Hepatitis B virus and hepatitis C virus reactivation in cancer patients receiving novel anticancer therapies[J].Clin Microbiol Infect,2022,28(10):1321.

[40]ZURAWSKA U,HICKS L K,WOO G,et al.Hepatitis B virus screening before chemotherapy for lymphoma:a cost-effectiveness analysis[J].J Clin Oncol,2012,30(26):3167.

[41]WONG W W,HICKS L K,TU H A,et al.Hepatitis B virus screening before adjuvant chemotherapy in patients with earlystage breast cancer:a cost-effectiveness analysis[J].Breast Cancer Res Treat,2015,151(3):639.

[42]SETO W K,CHAN T S,HWANG Y Y,et al.Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma:a prospective study[J].J Clin Oncol,2014,32(33):3736.

[43]LAU G,YU M L,WONG G,et al.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy[J].Hepatol Int,2021,15(5):1031.

[44]MORILLAS R M,LóPEZ SISAMóN D.Reactivation of hepatitis B associated with immunosuppressants and chemotherapy.Natural history,risk factors and recommendations for prevention[J].Med Clin,2019,152(3):107.